Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sukhvinder Johal"'
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-11 (2018)
Abstract Background We evaluated the cost-effectiveness of nivolumab versus everolimus in patients with advanced renal cell carcinoma (RCC) from a US payer perspective. Methods A partitioned survival model consisting of three health states, progressi
Externí odkaz:
https://doaj.org/article/1df5e660f8bd4b3391bf604100d0b086
Autor:
Sukhvinder Johal, Miguel Miranda, Tina Sarbajna, Xiaojin Shi, Alastair Greystoke, Melissa Johnson
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb6b6a4254e41b2966ca162339d601b
https://doi.org/10.1136/jitc-2022-sitc2022.0581
https://doi.org/10.1136/jitc-2022-sitc2022.0581
Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
Publikováno v:
J Thorac Dis
Background Small-cell lung cancer (SCLC) accounts for 12-15% of lung cancers and is associated with poor survival outcomes and high symptom burden. This study employed a broad, systematic search strategy and timeframe to identify evidence on real-wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab134ef6a1cd3c3962b4b96fd6b1fe1
https://europepmc.org/articles/PMC8264706/
https://europepmc.org/articles/PMC8264706/
Publikováno v:
International Journal of Technology Assessment in Health Care. 35:69-70
IntroductionDrug development is a risky business. Manufacturers are faced with the dilemma of whether or not to invest at any stage in the development process. Even once marketing authorization has been attained, payers are becoming increasingly dema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a2e23c1ad73cc835db4252ae280d73
https://doi.org/10.1017/s026646231900268x
https://doi.org/10.1017/s026646231900268x
Autor:
F Calado, Jean-Bernard Gruenberger, Ricardo Viana, D. Viriato, Sukhvinder Johal, Davide Carvalho, S.H. Ong, José Silva-Nunes
Publikováno v:
Journal of medical economics. 17(7)
To evaluate the cost-effectiveness of vildagliptin plus metformin vs generic sulphonylurea plus metformin in patients with type 2 diabetes mellitus, not controlled with metformin, from a Portuguese healthcare system perspective.A cost-effectiveness m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04e6705d04eeb639306285bfdd001d6
https://pubmed.ncbi.nlm.nih.gov/24708176
https://pubmed.ncbi.nlm.nih.gov/24708176
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 33(3)
In the UK, methicillin-resistant Staphylococcus aureus (MRSA)-associated skin and soft tissue infections (SSTIs) are predominantly managed in the hospital using intravenous (IV) glycopeptides. We set out to explore the potential for and relative heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6513b25d7193ece7a1f094e205eacaf2
https://pubmed.ncbi.nlm.nih.gov/24838676
https://pubmed.ncbi.nlm.nih.gov/24838676
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Infection; Dec2011, Vol. 63 Issue 6, pe54-e54, 1p